CASP8 and fatty liver disease: Furthermore, limonin can reduce hepatic steatosis, lipid accumulation, and the expression of p-STAT3/STAT3, caspase-8, and prostaglandin-endoperoxide synthase 2, and improve the inflammatory response of non-alcoholic fatty liver (Wang W. et al., 2023).